Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Other Non-Current Assets (2015 - 2026)

Mesoblast (MESO) posted Other Non-Current Assets of $1.2 million for Q4 2025, down 7.87% sequentially from $1.3 million in Q2 2025, and down 10.43% YoY from $1.3 million in Q4 2024.

Analysis

Mesoblast (MESO) Other Non-Current Assets (2015 - 2026) Analysis & Trends

Mesoblast has reported Other Non-Current Assets for 11 years, with the latest figure at $1.2 million in Q4 2025.

  • Quarterly Other Non-Current Assets fell 10.43% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 10.43% YoY) and the FY2025 annual result came in at $1.3 million, down 38.34% from the prior year.
  • Other Non-Current Assets retreated to $1.2 million in Q4 2025 per MESO's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $3.2 million in Q1 2021 and troughed at $1.2 million in Q4 2025.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2021 and 2023: Other Non-Current Assets tumbled 47.93% in 2021, then grew 21.03% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $2.0 million in 2021, then dropped by 1.74% to $1.9 million in 2022, then rose by 16.6% to $2.2 million in 2023, then sank by 40.52% to $1.3 million in 2024, then decreased by 10.43% to $1.2 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.2 million, $1.3 million, and $1.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - 1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Dec 31, 2025 1.19 Mn
Jun 30, 2025 1.30 Mn
Dec 31, 2024 1.33 Mn
Jun 30, 2024 397,000.00
Dec 31, 2023 2.24 Mn
Jun 30, 2023 398,000.00
Mar 31, 2023 2.39 Mn
Dec 31, 2022 1.92 Mn
Sep 30, 2022 1.90 Mn
Jun 30, 2022 413,000.00
Mar 31, 2022 1.97 Mn
Dec 31, 2021 1.96 Mn
Sep 30, 2021 1.95 Mn
Jun 30, 2021 451,000.00
Mar 31, 2021 3.20 Mn
Dec 31, 2020 3.21 Mn
Sep 30, 2020 3.33 Mn
Jun 30, 2020 3.31 Mn
Mar 31, 2020 3.24 Mn